Genetic / Immune defects may be imparing ability to fight Covid
https://www.theguardian.com/world/2020/sep/24/genetic-immune-defects-may-impair-ability-fight-covid-19
www.covidhge.com
In papers published in the journal Science, the Covid Human Genetic Effort international consortium describes two glitches in severely ill Covid-19 patients that prevent them from making a frontline immune molecule called type 1 interferon.
The patients would have carried these glitches for years before the pandemic, or in the case of the genetic errors, all their lives.
The discovery may help to explain a mystery surrounding the coronavirus:
why it leaves some sufferers sick or dying in intensive care, while others remain barely affected or asymptomatic.
Together, the two types of error account for about 15% of life-threatening Covid-19 cases
.....
Casanova suspects human genetics will end up explaining the majority of such cases, however,
because the consortium has only looked for mutations in 13 of the 300-odd type 1 interferon-related genes so far – already a huge undertaking.
Many other genes, including ones not related to interferon, could affect a person’s response to the virus.
Type 1 interferon is a molecule produced by the immune system as soon as it detects infection.
It works by stopping a virus from replicating.
If this first-line defence is effective, a person may not even feel unwell.
Even if it is not, it buys the body time to mount an immune response that is more targeted to the virus in question, involving antibodies and immune cells.
Without interferon, severely ill Covid-19 patients rely solely on this second defence mechanism,
which may take several days to reach full strength
– giving the Sars-CoV-2 virus a head start on damaging the body’s tissues.